Sunstone Hotel Invs New (SHO) Shareholder Global Endowment Management LP Decreased Position by $1.87 Million; Temasek Holdings Private LTD Has Increased Alexion Pharmaceuticals (ALXN) Position by $7.34 Million

January 18, 2018 - By Marie Mckinney

Temasek Holdings Private Ltd increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 3.61% based on its latest 2017Q3 regulatory filing with the SEC. Temasek Holdings Private Ltd bought 52,403 shares as the company’s stock declined 11.63% while stock markets rallied. The institutional investor held 1.51M shares of the health care company at the end of 2017Q3, valued at $211.18M, up from 1.45M at the end of the previous reported quarter. Temasek Holdings Private Ltd who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $27.28B market cap company. The stock decreased 1.90% or $2.36 during the last trading session, reaching $122.12. About 2.07 million shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since January 18, 2017 and is downtrending. It has underperformed by 34.82% the S&P500.

Global Endowment Management Lp decreased its stake in Sunstone Hotel Invs Inc New (SHO) by 60.85% based on its latest 2017Q3 regulatory filing with the SEC. Global Endowment Management Lp sold 116,860 shares as the company’s stock rose 4.30% with the market. The institutional investor held 75,200 shares of the consumer services company at the end of 2017Q3, valued at $1.21M, down from 192,060 at the end of the previous reported quarter. Global Endowment Management Lp who had been investing in Sunstone Hotel Invs Inc New for a number of months, seems to be less bullish one the $873.96M market cap company. The stock increased 1.44% or $0.24 during the last trading session, reaching $16.94. About 2.50M shares traded or 60.66% up from the average. Sunstone Hotel Investors, Inc. (NYSE:SHO) has risen 34.87% since January 18, 2017 and is uptrending. It has outperformed by 18.17% the S&P500.

Investors sentiment increased to 1.58 in 2017 Q3. Its up 0.32, from 1.26 in 2017Q2. It is positive, as 15 investors sold SHO shares while 54 reduced holdings. 31 funds opened positions while 78 raised stakes. 245.55 million shares or 1.51% more from 241.88 million shares in 2017Q2 were reported. Presima invested 0.67% in Sunstone Hotel Investors, Inc. (NYSE:SHO). Glenmede Tru Na holds 18,144 shares. Pnc Fincl Service Gp owns 0% invested in Sunstone Hotel Investors, Inc. (NYSE:SHO) for 104 shares. American Century Incorporated has invested 0.03% in Sunstone Hotel Investors, Inc. (NYSE:SHO). 341,000 are held by Apg Asset Nv. Aperio Group Ltd Limited Liability Company holds 0% in Sunstone Hotel Investors, Inc. (NYSE:SHO) or 40,110 shares. 3.69M are owned by Franklin Resource. Cornerstone Management has 0.05% invested in Sunstone Hotel Investors, Inc. (NYSE:SHO). Frontier Cap Mgmt Lc has invested 0.49% in Sunstone Hotel Investors, Inc. (NYSE:SHO). 211,125 were accumulated by Susquehanna Intl Group Llp. Adelante Management invested in 0.9% or 1.02 million shares. Legal And General Gp Public Limited Company reported 0.01% of its portfolio in Sunstone Hotel Investors, Inc. (NYSE:SHO). Blackrock Inc reported 0.02% in Sunstone Hotel Investors, Inc. (NYSE:SHO). Morgan Stanley holds 0% or 381,131 shares. Vident Investment Advisory Limited invested 0.14% in Sunstone Hotel Investors, Inc. (NYSE:SHO).

Analysts await Sunstone Hotel Investors, Inc. (NYSE:SHO) to report earnings on February, 20. They expect $0.25 earnings per share, down 13.79% or $0.04 from last year’s $0.29 per share. SHO’s profit will be $12.90 million for 16.94 P/E if the $0.25 EPS becomes a reality. After $0.31 actual earnings per share reported by Sunstone Hotel Investors, Inc. for the previous quarter, Wall Street now forecasts -19.35% negative EPS growth.

Global Endowment Management Lp, which manages about $5.46 billion and $709.50M US Long portfolio, upped its stake in Liberty Interactive Corp by 6,100 shares to 13,360 shares, valued at $769,000 in 2017Q3, according to the filing. It also increased its holding in Retail Pptys Amer Inc (NYSE:RPAI) by 48,900 shares in the quarter, for a total of 266,720 shares, and has risen its stake in Stericycle Inc (NASDAQ:SRCL).

Since December 14, 2017, it had 0 buys, and 1 insider sale for $308,267 activity.

Among 18 analysts covering Sunstone Hotel Investors Inc (NYSE:SHO), 3 have Buy rating, 3 Sell and 12 Hold. Therefore 17% are positive. Sunstone Hotel Investors Inc has $18 highest and $12.50 lowest target. $15.39’s average target is -9.15% below currents $16.94 stock price. Sunstone Hotel Investors Inc had 41 analyst reports since July 21, 2015 according to SRatingsIntel. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, August 1 report. Robert W. Baird maintained the stock with “Hold” rating in Wednesday, September 20 report. The rating was downgraded by Wells Fargo to “Market Perform” on Tuesday, December 19. The rating was initiated by Instinet on Wednesday, December 14 with “Neutral”. The stock of Sunstone Hotel Investors, Inc. (NYSE:SHO) has “Outperform” rating given on Friday, November 20 by FBR Capital. Bank of America downgraded the shares of SHO in report on Tuesday, July 21 to “Underperform” rating. The firm has “Hold” rating by SunTrust given on Tuesday, October 17. The rating was maintained by FBR Capital on Thursday, November 3 with “Outperform”. The firm has “Equal-Weight” rating given on Wednesday, August 12 by Barclays Capital. The firm has “Neutral” rating given on Monday, August 22 by Citigroup.

Among 28 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 23 have Buy rating, 0 Sell and 5 Hold. Therefore 82% are positive. Alexion Pharmaceuticals Inc. has $257 highest and $82 lowest target. $169.33’s average target is 38.66% above currents $122.12 stock price. Alexion Pharmaceuticals Inc. had 89 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, September 12. The stock has “Buy” rating by SunTrust on Thursday, January 7. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Outperform” rating by Credit Suisse on Monday, July 11. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Buy” rating given on Friday, July 31 by Brean Capital. Wedbush initiated the shares of ALXN in report on Friday, September 23 with “Neutral” rating. The company was maintained on Wednesday, June 7 by Jefferies. Deutsche Bank initiated it with “Buy” rating and $164 target in Thursday, November 3 report. The company was upgraded on Tuesday, September 5 by JP Morgan. Stifel Nicolaus maintained the shares of ALXN in report on Friday, July 29 with “Buy” rating. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Hold” rating given on Friday, September 23 by Jefferies.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.20, from 1.37 in 2017Q2. It dived, as 36 investors sold ALXN shares while 174 reduced holdings. 78 funds opened positions while 167 raised stakes. 206.89 million shares or 0.54% less from 208.01 million shares in 2017Q2 were reported. Weiss Asset Management Limited Partnership stated it has 0.02% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Sumitomo Mitsui Asset Mgmt Com stated it has 0.04% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Virginia Retirement Sys Et Al, Virginia-based fund reported 117,100 shares. 66,351 are held by Bogle Invest Management Lp De. Rockefeller, a New York-based fund reported 8,550 shares. Glg Ltd Company invested in 39,133 shares. Moreover, Wellington Management Grp Llp has 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 2,314 shares. Moreover, Fifth Third Retail Bank has 0.06% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Florida-based Ifc Inc Fl has invested 0.06% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Pacad Inv holds 0.41% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 13,200 shares. Illinois-based Magnetar Fincl Ltd Co has invested 0.01% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Tourbillon LP has invested 5.35% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Mackenzie Finance Corp holds 0% or 2,078 shares. Us National Bank & Trust De holds 31,744 shares or 0.01% of its portfolio. Bnp Paribas Asset Management Holdg Sa holds 0.01% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 9,401 shares.

Temasek Holdings Private Ltd, which manages about $17.17B US Long portfolio, decreased its stake in Ihs Markit Ltd by 3.84 million shares to 17.34 million shares, valued at $764.20M in 2017Q3, according to the filing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: